HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 131 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,358,637 | +22.4% | 1,527,713 | +15.5% | 0.71% | +35.8% |
| Q2 2023 | $47,693,197 | +8.0% | 1,322,240 | +14.3% | 0.52% | +4.2% |
| Q1 2023 | $44,170,478 | +22208.3% | 1,156,598 | +5683.0% | 0.50% | +8266.7% |
| Q2 2014 | $198,000 | -55.6% | 20,000 | -43.0% | 0.01% | -57.1% |
| Q1 2014 | $446,000 | -4.1% | 35,076 | +13.1% | 0.01% | 0.0% |
| Q4 2013 | $465,000 | +151.4% | 31,000 | +84.9% | 0.01% | +133.3% |
| Q3 2013 | $185,000 | – | 16,763 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |